Not only will this meeting look at the manufacturing processes and regulatory challenges for biologics and biosimilars, it will also feature a track dedicated to the complex manufacturing of cell and gene therapies. Attracting experts working in all areas of bioprocessing and process analytics, including cell line development, single-use technologies, continuous processing, automated systems, real-time monitoring, CMC/GMP practices, QbD strategies, purification optimisation, scale-down models and effective scale-up strategies, this conference will examine the latest developments in the technologies and methods used for biopharmaceutical production.